| Literature DB >> 35294694 |
Xinyu Zhao1, Cecilia Milford2, Jenni Smit2, Bongiwe Zulu2, Peter Boyd1, R Karl Malcolm3, Mags Beksinska2.
Abstract
Steroid-releasing vaginal rings are available for contraception and estrogen replacement therapy, and a new antiretroviral-releasing ring was recently approved for HIV prevention. Marketed rings are white or transparent in appearance, non-scented, and supplied as one-size-fits-all devices with diameters ranging from 54 to 56 mm. In this study, drug-free silicone elastomer rings were manufactured in different sizes, colors and scents, and the opinions/preferences of 16 women (eThekwini District, South Africa; 20-34 years) assessed through focus group discussions and thematic analysis. Opinions varied on ring color and scent, with some women preferring specific colors or scent intensities, while for others these attributes were unimportant. Concerns about color and scent were linked to perceptions around vaginal health and safety related to chemical composition. There was greater agreement on preferred ring size; flexibility and width were considered important factors for insertion and comfort. Greater choice with ring products could facilitate acceptability and overall uptake.Entities:
Keywords: Contraception; HIV prevention; Pharmaceutical drug product design; User-centred design
Mesh:
Year: 2022 PMID: 35294694 PMCID: PMC8924943 DOI: 10.1007/s10461-022-03596-7
Source DB: PubMed Journal: AIDS Behav ISSN: 1090-7165
Fig. 1Dimensions (overall diameter vs. cross-sectional diameter) of vaginal rings, both marketed products (blue circles and orange squares) and those previously tested in the clinic and reported in the scientific and patent literature (black circles and squares). Note that rings are further sub-classified according to polymer type—silicone elastomer (circles) and thermoplastic (squares). Large white circles represent the drug-free rings used in this study
Fig. 2A—Examples of marketed vaginal rings, showing conventional white or transparent/colorless appearance. B—Examples of colored products administered vaginally—Caya® and Singa® diaphragms, and menstrual cups
Fig. 3Dimensions (cross-sectional and external diameters; drawn to scale) and photographs of the four different ring designs used in this study. See Fig. 1 for comparison of ring dimensions with those of marketed and experimental rings
Silicone elastomer vaginal rings (dimensions 57.6 mm overall diameter and 7.9 mm cross-sectional diameter) having different colors were obtained by incorporating various concentrations of titanium dioxide and color masterbatches into MED-4870 silicone elastomer
| Ring color | Titanium dioxide concentration (% w/w) | Concentration of color masterbatches (% w/w) |
|---|---|---|
| White | 0.4 | – |
| Pastel orange | 0.4 | 0.02 MED-4900–4 |
| Light pink | 0.4 | 0.05 MED-4900–3 |
| Pastel green | 0.4 | 0.10 MED2-4900–6 |
| Mellow yellow | 0.4 | 0.01 MED-4900–4 + 0.02 MED-4900–5 |
| Mauve | 0.3 | 0.02 MED-4900–3 + 0.04 MED1-4900–7 |
Fig. 4Ring colors from top row left to right—white, pastel orange, light pink; bottom row—pastel green, mellow yellow and mauve. See also Table 1
Silicone elastomer vaginal rings (dimensions 57.6 mm overall diameter and 7.9 mm cross-sectional diameter) having different scents were obtained by incorporating various essential oils into Silbione® Biomedical LSR D1XX-TB
| Ring scent | Essential oil concentration (% w/w) |
|---|---|
| Lemon | 5.0 |
| Grapefruit | 3.0 |
| Spearmint | 2.0 |
| Camphor | 1.0 |
| Lavender | 0.50 |
Demographic characteristics of focus group participants
| Demographics | (N = 16) |
|---|---|
| Age (mean, range) | 26.9 (20–34) |
| Ever pregnant (%, N) | 75.0 (12) |
| Number of pregnancies (mean, range) | 1.8 (0–5) |
| Source of household income (%, Na) | |
| Employment (full/part time/casual) | 68.8 (11) |
| Government grant | 93.8 (15) |
| Financial support from outside household | 18.8 (3) |
| Education (grade) (%, N) | |
| Secondary incomplete | 12.5 (2) |
| Completed secondary | 68.8 (11) |
| Tertiary | 18.8 (3) |
| Current relationship (%, N) | |
| Regular partner, not living together | 75.0 (12) |
| Regular partner, living together | 18.8 (3) |
| No current relationship | 6.3 (1) |
| Vaginal product experience* (%, N) | |
| Vaginal ring | 50.0 (8) |
| Female condom | 43.8 (7) |
| Vaginal applicator | 43.8 (7) |
| Tampon | 37.5 (6) |
| Vaginal tablet | 37.5 (6) |
| Vaginal film | 31.3 (5) |
| Diaphragm | 6.3 (1) |
| Menstrual cup | 0.0 (0) |
aMultiple choice options